1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
2
|
Buechler SA, Stephens MT, Hummon AB,
Ludwig K, Cannon E, Carter TC, Resnick J, Gökmen-Polar Y and Badve
SS: ColoType: A forty gene signature for consensus molecular
subtyping of colorectal cancer tumors using whole-genome assay or
targeted RNA-sequencing. Sci Rep. 10(12123)2020.PubMed/NCBI View Article : Google Scholar
|
3
|
Guinney J, Dienstmann R, Wang X, de
Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda
G, Angelino P, et al: The consensus molecular subtypes of
colorectal cancer. Nat Med. 21:1350–1356. 2015.PubMed/NCBI View
Article : Google Scholar
|
4
|
Sirinukunwattana K, Domingo E, Richman SD,
Redmond KL, Blake A, Verrill C, Leedham SJ, Chatzipli A, Hardy C,
Whalley CM, et al: Image-based consensus molecular subtype (imCMS)
classification of colorectal cancer using deep learning. Gut.
70:544–554. 2021.PubMed/NCBI View Article : Google Scholar
|
5
|
Japanese Society for Cancer of the Colon
and Rectum. Japanese classification of colorectal, appendiceal, and
anal carcinoma: The 3d english edition (secondary publication). J
Anus Rectum Colon. 3:175–195. 2019.PubMed/NCBI View Article : Google Scholar
|
6
|
Pei JP, Zhang CD, Fu X, Ba Y, Yue S, Zhao
ZM and Dai DQ: A novel TNM classification for colorectal cancers
based on the metro-ticket paradigm. J Cancer. 12:3299–3306.
2021.PubMed/NCBI View Article : Google Scholar
|
7
|
Tebala GD, Hameed W, Di Saverio S, Gallo G
and Bond-Smith G: Proposal and validation of a new classification
of surgical outcomes after colorectal resections within an enhanced
recovery programme. Surg Res Pract. 2021(8864555)2021.PubMed/NCBI View Article : Google Scholar
|
8
|
Shabanzadeh DM, Sørensen LT and Jørgensen
T: Gallstone disease and mortality: A cohort study. Int J Public
Health. 62:353–360. 2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Manzia TM, Quaranta C, Filingeri V, Toti
L, Anselmo A, Tariciotti L, De Carolis G, Cacciola R, Di Lorenzo N,
Sorge R, et al: Feasibility and cost effectiveness of ambulatory
laparoscopic cholecystectomy. A retrospective cohort study. Ann Med
Surg (Lond). 55:56–61. 2020.PubMed/NCBI View Article : Google Scholar
|
10
|
Sutherland JM, Mok J, Liu G, Karimuddin A
and Crump T: A cost-utility study of laparoscopic cholecystectomy
for the treatment of symptomatic gallstones. J Gastrointest Surg.
24:1314–1319. 2020.PubMed/NCBI View Article : Google Scholar
|
11
|
Teixeira UF, Goldoni MB, Machry MC, Ceccon
PN, Fontes PR and Waechter FL: AMBULATORY LAPAROSCOPIC
CHOLECYSTECTOMY IS SAFE AND COST-EFFECTIVE: A Brazilian single
center experience. Arq Gastroenterol. 53:103–107. 2016.PubMed/NCBI View Article : Google Scholar
|
12
|
Bundgaard NS, Bohm A, Hansted AK and
Skovsen AP: Early laparoscopic cholecystectomy for acute
cholecystitis is safe regardless of timing. Langenbecks Arch Surg.
406:2367–2373. 2021.PubMed/NCBI View Article : Google Scholar
|
13
|
Chan KS, Mohan R, Low JK, Junnarkar SP,
Huey CWT and Shelat VG: Elderly patients (≥80 years) with acute
calculous cholangitis have similar outcomes as non-elderly patients
(<80 years): Propensity score-matched analysis. World J Hepatol.
13:456–471. 2021.PubMed/NCBI View Article : Google Scholar
|
14
|
Lin YN, Wu YT, Fu CY, Liao CH, Cheng CT,
Wang SY, Lin BC, Hsu YP, Kang SC, Liu EH, et al: Evaluating the
advantages of treating acute cholecystitis by following the Tokyo
guidelines 2018 (TG18): A study emphasizing clinical outcomes and
medical expenditures. Surg Endosc. 35:6623–6632. 2020.PubMed/NCBI View Article : Google Scholar
|
15
|
Wakabayashi G, Iwashita Y, Hibi T, Takada
T, Strasberg SM, Asbun HJ, Endo I, Umezawa A, Asai K, Suzuki K, et
al: Tokyo guidelines 2018: surgical management of acute
cholecystitis: Safe steps in laparoscopic cholecystectomy for acute
cholecystitis (with videos). J Hepatobiliary Pancreat Sci.
25:73–86. 2018.PubMed/NCBI View
Article : Google Scholar
|
16
|
Gál I, Szívós J, Jaberansari MT and Szabó
Z: Laparoscopic cholecystectomy. Risk of missed pathology of other
organs. Surg Endosc. 12:825–827. 1998.PubMed/NCBI View Article : Google Scholar
|
17
|
Icoz G, Makay O, Dayangac M, Zeytunlu M,
Kilic M and Korkut M: Missed intra-abdominal malignancies after
laparoscopic cholecystectomy. Ann Saudi Med. 25:172–173.
2005.PubMed/NCBI View Article : Google Scholar
|
18
|
Ishida H, Ohsawa T, Murata N, Fujioka M
and Hashimoto D: Risk of missing colorectal cancer during
laparoscopic cholecystectomy. Surg Today. 32:392–396.
2002.PubMed/NCBI View Article : Google Scholar
|
19
|
Wysocki A, Lejman W and Bobrzynski A:
Abdominal malignancies missed during laparoscopic cholecystectomy.
Surg Endosc. 15:959–961. 2001.PubMed/NCBI View Article : Google Scholar
|
20
|
Malouf AJ, Murray AW and MacGregor AB:
Major intra-abdominal pathology missed at laparoscopic
cholecystectomy. Br J Surg. 87:1434–1435. 2000.PubMed/NCBI View Article : Google Scholar
|
21
|
Radmard AR, Merat S, Kooraki S, Ashraf M,
Keshtkar A, Sharafkhah M, Jafari E, Malekzadeh R and Poustchi H:
Gallstone disease and obesity: A population-based study on
abdominal fat distribution and gender differences. Ann Hepatol.
14:702–709. 2015.PubMed/NCBI
|
22
|
Sun H, Tang H, Jiang S, Zeng L, Chen EQ,
Zhou TY and Wang YJ: Gender and metabolic differences of gallstone
diseases. World J Gastroenterol. 15:1886–1891. 2009.PubMed/NCBI View Article : Google Scholar
|
23
|
Bonfrate L, Wang DQ, Garruti G and
Portincasa P: Obesity and the risk and prognosis of gallstone
disease and pancreatitis. Best Pract Res Clin Gastroenterol.
28:623–635. 2014.PubMed/NCBI View Article : Google Scholar
|
24
|
Wang Y, Yu X, Zhao QZ, Zheng S, Qing WJ,
Miao CD and Sanjay J: Thyroid dysfunction, either hyper or
hypothyroidism, promotes gallstone formation by different
mechanisms. J Zhejiang Univ Sci B. 17:515–525. 2016.PubMed/NCBI View Article : Google Scholar
|
25
|
Hofmann AF: The continuing importance of
bile acids in liver and intestinal disease. Arch Intern Med.
159:2647–2658. 1999.PubMed/NCBI View Article : Google Scholar
|
26
|
Ridlon JM, Kang DJ and Hylemon PB: Bile
salt biotransformations by human intestinal bacteria. J Lipid Res.
47:241–259. 2006.PubMed/NCBI View Article : Google Scholar
|
27
|
Bernstein H, Bernstein C, Payne CM and
Dvorak K: Bile acids as endogenous etiologic agents in
gastrointestinal cancer. World J Gastroenterol. 15:3329–3340.
2009.PubMed/NCBI View Article : Google Scholar
|
28
|
Payne CM, Bernstein C, Dvorak K and
Bernstein H: Hydrophobic bile acids, genomic instability, Darwinian
selection, and colon carcinogenesis. Clin Exp Gastroenterol.
1:19–47. 2008.PubMed/NCBI View Article : Google Scholar
|
29
|
Narahara H, Tatsuta M, Iishi H, Baba M,
Uedo N, Sakai N, Yano H and Ishiguro S: K-ras point mutation is
associated with enhancement by deoxycholic acid of colon
carcinogenesis induced by azoxymethane, but not with its
attenuation by all-trans-retinoic acid. Int J Cancer. 88:157–161.
2000.PubMed/NCBI View Article : Google Scholar
|
30
|
Scott DW, Mutamba S, Hopkins RG and Loo G:
Increased GADD gene expression in human colon epithelial cells
exposed to deoxycholate. J Cell Physiol. 202:295–303.
2005.PubMed/NCBI View Article : Google Scholar
|
31
|
Payne CM, Weber C, Crowley-Skillicorn C,
Dvorak K, Bernstein H, Bernstein C, Holubec H, Dvorakova B and
Garewal H: Deoxycholate induces mitochondrial oxidative stress and
activates NF-kappaB through multiple mechanisms in HCT-116 colon
epithelial cells. Carcinogenesis. 28:215–222. 2007.PubMed/NCBI View Article : Google Scholar
|
32
|
Badvie S, Hanna-Morris A, Andreyev HJ,
Cohen P, Saini S and Allen-Mersh TG: A ‘field change’ of inhibited
apoptosis occurs in colorectal mucosa adjacent to colorectal
adenocarcinoma. J Clin Pathol. 59:942–946. 2006.PubMed/NCBI View Article : Google Scholar
|
33
|
Di Ciaula A, Wang DQ, Molina-Molina E,
Lunardi Baccetto R, Calamita G, Palmieri VO and Portincasa P: Bile
acids and cancer: Direct and environmental-dependent effects. Ann
Hepatol. 16 (Suppl 1: s3-105):S87–S105. 2017.PubMed/NCBI View Article : Google Scholar
|
34
|
Saracut C, Molnar C, Russu C, Todoran N,
Vlase L, Turdean S, Voidazan S and Copotoiu C: Secondary bile acids
effects in colon pathology. Experimental mice study. Acta Cir Bras.
30:624–631. 2015.PubMed/NCBI View Article : Google Scholar
|
35
|
Schulz MD, Atay C, Heringer J, Romrig FK,
Schwitalla S, Aydin B, Ziegler PK, Varga J, Reindl W, Pommerenke C,
et al: High-fat-diet-mediated dysbiosis promotes intestinal
carcinogenesis independently of obesity. Nature. 514:508–512.
2014.PubMed/NCBI View Article : Google Scholar
|
36
|
Islam KB, Fukiya S, Hagio M, Fujii N,
Ishizuka S, Ooka T, Ogura Y, Hayashi T and Yokota A: Bile acid is a
host factor that regulates the composition of the cecal microbiota
in rats. Gastroenterology. 141:1773–1781. 2011.PubMed/NCBI View Article : Google Scholar
|
37
|
Higashimura Y, Naito Y, Takagi T, Uchiyama
K, Mizushima K, Ushiroda C, Ohnogi H, Kudo Y, Yasui M, Inui S, et
al: Protective effect of agaro-oligosaccharides on gut dysbiosis
and colon tumorigenesis in high-fat diet-fed mice. Am J Physiol
Gastrointest Liver Physiol. 310:G367–G375. 2016.PubMed/NCBI View Article : Google Scholar
|
38
|
Donohoe DR, Holley D, Collins LB,
Montgomery SA, Whitmore AC, Hillhouse A, Curry KP, Renner SW,
Greenwalt A, Ryan EP, et al: A gnotobiotic mouse model demonstrates
that dietary fiber protects against colorectal tumorigenesis in a
microbiota- and butyrate-dependent manner. Cancer Discov.
4:1387–1397. 2014.PubMed/NCBI View Article : Google Scholar
|
39
|
Ocvirk S and O'Keefe SJ: Influence of bile
acids on colorectal cancer risk: Potential mechanisms mediated by
diet-gut microbiota interactions. Curr Nutr Rep. 6:315–322.
2017.PubMed/NCBI View Article : Google Scholar
|
40
|
O'Keefe SJ: Diet, microorganisms and their
metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol.
13:691–706. 2016.PubMed/NCBI View Article : Google Scholar
|
41
|
Ward JB, Lajczak NK, Kelly OB, O'Dwyer AM,
Giddam AK, Gabhann JN, Franco P, Tambuwala MM, Jefferies CA, Keely
S, et al: Ursodeoxycholic acid and lithocholic acid exert
anti-inflammatory actions in the colon. Am J Physiol Gastrointest
Liver Physiol. 312:G550–G558. 2017.PubMed/NCBI View Article : Google Scholar
|
42
|
Chen YK, Yeh JH, Lin CL, Peng CL, Sung FC,
Hwang IM and Kao CH: Cancer risk in patients with cholelithiasis
and after cholecystectomy: A nationwide cohort study. J
Gastroenterol. 49:923–931. 2014.PubMed/NCBI View Article : Google Scholar
|
43
|
Yoon WJ, Kim HN, Park E, Ryu S, Chang Y,
Shin H, Kim HL and Yi SY: The impact of cholecystectomy on the gut
microbiota: A case-control study. J Clin Med. 8(79)2019.PubMed/NCBI View Article : Google Scholar
|
44
|
Ren X, Xu J, Zhang Y, Chen G, Zhang Y,
Huang Q and Liu Y: Bacterial alterations in post-cholecystectomy
patients are associated with colorectal cancer. Front Oncol.
10(1418)2020.PubMed/NCBI View Article : Google Scholar
|
45
|
Ekbom A, Yuen J, Adami HO, McLaughlin JK,
Chow WH, Persson I and Fraumeni JF Jr: Cholecystectomy and
colorectal cancer. Gastroenterology. 105:142–147. 1993.PubMed/NCBI View Article : Google Scholar
|
46
|
Alley PG and Lee SP: The increased risk of
proximal colonic cancer after cholecystectomy. Dis Colon Rectum.
26:522–524. 1983.PubMed/NCBI View Article : Google Scholar
|
47
|
Vernick LJ and Kuller LH: Cholecystectomy
and right-sided colon cancer: An epidemiological study. Lancet.
2:38l–383. 1981.PubMed/NCBI View Article : Google Scholar
|
48
|
Johansen C, Chow WH, Jorgensen T,
Mellemkjaer L, Engholm G and Olsen JH: Risk of colorectal cancer
and other cancers in patients with gall stones. Gut. 39:439–443.
1996.PubMed/NCBI View Article : Google Scholar
|
49
|
Zhang Y, Liu H, Li L, Ai M, Gong Z, He Y,
Dong Y, Xu S, Wang J, Jin B, et al: Cholecystectomy can increase
the risk of colorectal cancer: A meta-analysis of 10 cohort
studies. PLoS One. 12(e0181852)2017.PubMed/NCBI View Article : Google Scholar
|
50
|
Lagergren J, Ye W and Ekbom A: Intestinal
cancer after cholecystectomy: Is bile involved in carcinogenesis?
Gastroenterology. 121:542–547. 2001.PubMed/NCBI View Article : Google Scholar
|
51
|
Zhang Y, Liu H, Li L, Ai M, Gong Z, He Y,
Dong Y, Xu S, Wang J, Jin B, et al: Correction: Cholecystectomy can
increase the risk of colorectal cancer: A meta-analysis of 10
cohort studies. PLoS One. 13(e0191587)2018.PubMed/NCBI View Article : Google Scholar
|
52
|
Shabanzadeh DM, Sørensen LT and Jørgensen
T: Association between screen-detected gallstone disease and cancer
in a cohort study. Gastroenterology. 152:1965–1974.e1.
2017.PubMed/NCBI View Article : Google Scholar
|
53
|
Gosavi S, Mishra RR and Kumar VP: Study on
the relation between colorectal cancer and gall bladder disease. J
Clin Diagn Res. 11:OC25–OC27. 2017.PubMed/NCBI View Article : Google Scholar
|